<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00930137</url>
  </required_header>
  <id_info>
    <org_study_id>INAF-2009-084</org_study_id>
    <nct_id>NCT00930137</nct_id>
  </id_info>
  <brief_title>Ruminant Trans Fats and the Risk of Cardiovascular Disease in Women</brief_title>
  <acronym>TRANSW</acronym>
  <official_title>Ruminant Trans Fats and the Risk of Cardiovascular Disease in Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laval University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institute of Nutraceuticals and Functional Foods</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dairy Farmers of Canada</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dairy Australia</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Laval University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      While the deleterious effects of trans fat from industrial sources (iTFA) on cardiovascular
      health are well established, the impact of TFA from ruminants (rTFA) on cardiovascular risk
      factors has not been as well characterized. We have previously shown in men that a very high
      dietary intakes of rTFA (&gt;3.5% of energy) leads to unfavourable changes in lipid
      cardiovascular risk factors that are similar to those seen with iTFA. However, our data also
      indicated that achievable intakes of rTFA that remain well above the current human
      consumption (1.5% of energy intake) had neutral effects on plasma lipids and other
      cardiovascular disease (CVD) risk factors in men. Other studies have also suggested that the
      LDL and HDL response to very high dietary intakes of rTFA (&gt;5% of energy) in women may be
      different than in men.

      The general objective of the study is to investigate for the first time in a double-blind
      randomized controlled study the impact of high but yet achievable intake of ruminant trans
      fatty acids on plasma LDL-Cholesterol and other risk factors for CVD in healthy women.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ruminant trans fatty acids (rTFA) will come from an experimental butter formulated from dairy
      fat obtained after having modified the regimen of lactating cows. All diets will be identical
      in terms of menus, calories and macronutrient composition with the exception of TFA levels.
      All foods will be provided to study participants. Based on a 2500 kcal/day regimen, an intake
      of 4.1g of rTFA will represent 37 kcal/day (1.5% of energy intake) while the intake of 0.7 g
      of rTFA in the control diet will represent 6 calories (0.3% of energy). The 2 experimental
      diets will be formulated so that the percentage of daily calories from fat (33%),
      carbohydrates (52%) and proteins (15%) will meet the dietary recommendations of the American
      Heart Association and the NCEP for primary prevention of CVD.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma LDL-Cholesterol concentrations</measure>
    <time_frame>At the beginning of the study and the end of the 2 for-week diets</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood lipids and apolipoproteins (Total cholesterol, HDL-Cholesterol, Triglycerides, Apo A1, Apo B)</measure>
    <time_frame>At the beginning of the study and the end of the 2 for-week diets</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CRP</measure>
    <time_frame>At the beginning of the study and the end of the 2 for-week diets</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>At the beginning of the study and the end of the 2 for-week diets</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anthropometric measures (waist and hip circumferences)</measure>
    <time_frame>At the beginning of the study and the end of the 2 for-week diets</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">64</enrollment>
  <condition>Cardiovascular Disease</condition>
  <arm_group>
    <arm_group_label>High dairy trans fat</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>a diet rich in ruminant trans fatty acids (4.1 g/2500 kcal)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low dairy trans fat diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>a control diet (minimal dietary ruminant trans fatty acids, 0.7 g/2500 kcal)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>isocaloric for week diet</intervention_name>
    <description>Consumption of the 2 experimental diets
a diet rich in ruminant trans fatty acids (4.1 g/2500 kcal);
a control diet (minimal dietary ruminant trans fatty acids, 0.7 g/2500 kcal).</description>
    <arm_group_label>High dairy trans fat</arm_group_label>
    <arm_group_label>Low dairy trans fat diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy women using or not contraceptive agents or hormone supplementation

          -  For pre-menopausal women: regular menstrual cycle for the last 3 months (25- 35 days)

          -  LDL-Cholesterol concentration between 2.5 and 4.0 mmol/L

          -  Stable body weight (+/- 2 kg) for 6 months before the beginning of the study

          -  Smoking or not

        Exclusion Criteria:

          -  Previous history of cardiovascular disease, type 2 diabetes and monogenic dyslipidemia

          -  Subjects taking medications for hyperlipidemia or hypertension

          -  Endocrine disorders

          -  Body mass index &gt; 35 kg/m2

          -  Food allergies

          -  Women with extreme nutritional habits such as vegetarism or alcohol consumption &gt; 2
             drinks/day

          -  Elite athletes
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benoît Lamarche, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Nutraceutical and Functional Foods (INAF), Laval University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Patrick Couture, MD, FRCP (C, PhD)</last_name>
    <role>Study Director</role>
    <affiliation>Faculty of Medicine, Laval University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institute of Nutraceutical and Functional Foods (INAF), Laval University</name>
      <address>
        <city>Quebec</city>
        <zip>G1V 0A6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Motard-Bélanger A, Charest A, Grenier G, Paquin P, Chouinard Y, Lemieux S, Couture P, Lamarche B. Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease. Am J Clin Nutr. 2008 Mar;87(3):593-9.</citation>
    <PMID>18326596</PMID>
  </reference>
  <reference>
    <citation>Desroches S, Chouinard PY, Galibois I, Corneau L, Delisle J, Lamarche B, Couture P, Bergeron N. Lack of effect of dietary conjugated linoleic acids naturally incorporated into butter on the lipid profile and body composition of overweight and obese men. Am J Clin Nutr. 2005 Aug;82(2):309-19.</citation>
    <PMID>16087973</PMID>
  </reference>
  <reference>
    <citation>Mauger JF, Lichtenstein AH, Ausman LM, Jalbert SM, Jauhiainen M, Ehnholm C, Lamarche B. Effect of different forms of dietary hydrogenated fats on LDL particle size. Am J Clin Nutr. 2003 Sep;78(3):370-5.</citation>
    <PMID>12936917</PMID>
  </reference>
  <reference>
    <citation>Lichtenstein AH, Ausman LM, Jalbert SM, Schaefer EJ. Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels. N Engl J Med. 1999 Jun 24;340(25):1933-40. Erratum in: N Engl J Med 1999 Sep 9;341(11):856.</citation>
    <PMID>10379016</PMID>
  </reference>
  <reference>
    <citation>Chardigny JM, Destaillats F, Malpuech-Brugère C, Moulin J, Bauman DE, Lock AL, Barbano DM, Mensink RP, Bezelgues JB, Chaumont P, Combe N, Cristiani I, Joffre F, German JB, Dionisi F, Boirie Y, Sébédio JL. Do trans fatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects? Results of the trans Fatty Acids Collaboration (TRANSFACT) study. Am J Clin Nutr. 2008 Mar;87(3):558-66.</citation>
    <PMID>18326592</PMID>
  </reference>
  <reference>
    <citation>Tholstrup T, Raff M, Basu S, Nonboe P, Sejrsen K, Straarup EM. Effects of butter high in ruminant trans and monounsaturated fatty acids on lipoproteins, incorporation of fatty acids into lipid classes, plasma C-reactive protein, oxidative stress, hemostatic variables, and insulin in healthy young men. Am J Clin Nutr. 2006 Feb;83(2):237-43.</citation>
    <PMID>16469980</PMID>
  </reference>
  <reference>
    <citation>Oomen CM, Ocké MC, Feskens EJ, van Erp-Baart MA, Kok FJ, Kromhout D. Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study. Lancet. 2001 Mar 10;357(9258):746-51.</citation>
    <PMID>11253967</PMID>
  </reference>
  <reference>
    <citation>Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Trans fatty acids and cardiovascular disease. N Engl J Med. 2006 Apr 13;354(15):1601-13. Review.</citation>
    <PMID>16611951</PMID>
  </reference>
  <reference>
    <citation>Willett WC, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Rosner BA, Sampson LA, Hennekens CH. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet. 1993 Mar 6;341(8845):581-5.</citation>
    <PMID>8094827</PMID>
  </reference>
  <reference>
    <citation>Willett W, Mozaffarian D. Ruminant or industrial sources of trans fatty acids: public health issue or food label skirmish? Am J Clin Nutr. 2008 Mar;87(3):515-6.</citation>
    <PMID>18326587</PMID>
  </reference>
  <verification_date>March 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 29, 2009</study_first_submitted>
  <study_first_submitted_qc>June 29, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 30, 2009</study_first_posted>
  <last_update_submitted>March 4, 2013</last_update_submitted>
  <last_update_submitted_qc>March 4, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 5, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Laval University</investigator_affiliation>
    <investigator_full_name>Benoit Lamarche</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Cardiovascular disease</keyword>
  <keyword>Trans fatty acids</keyword>
  <keyword>Ruminant</keyword>
  <keyword>Blood lipids</keyword>
  <keyword>Lipoproteins</keyword>
  <keyword>Women</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

